Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raghav Sundar

Showing results (41-50 of 149) with videos related to

Pageof 15
Sort By:
British Journal of Anaesthesia|February 20, 2024
FRailty in Australian patients admitted to Intensive care unit after eLective CANCER-related SURGery: a retrospective multicentre cohort study (FRAIL-CANCER-SURG study)Ryan R Ling, Ryo Ueno, Muhammad Alamgeer, et al.
Thoracic Cancer|March 8, 2018
Resisting resistance to cancer immunotherapyWalter Sze-Tung Lam, Louis Zizhao Wang, Raheleh Roudi, et al.
Journal of Cancer Research and Clinical Oncology|May 22, 2023
Effects of prior therapies on outcomes with trifluridine/tipiracil in patients with metastatic gastric/gastroesophageal junction cancer in a randomized phase III trial (TAGS)Kohei Shitara, Ben George, Julien Taieb, et al.
Annals of Surgical Oncology|May 30, 2025
A Feasibility Study of Mass-Based Response Drug Screening to Guide Personalized Hyperthermic Intraperitoneal Chemotherapy for Appendiceal and Colorectal Adenocarcinoma with Peritoneal MetastasisJustin M Bader, Ava Ospina, Sean Liu, et al.
Annals of Surgical Oncology|October 3, 2022
ASO Author Reflections: Combination Intra-Peritoneal and Systemic Chemotherapy for Gastric Cancer with Peritoneal MetastasesDaryl K A Chia, Jia Jun Ang, Raghav Sundar, et al.
Lancet (London, England)|May 4, 2025
Gastric cancerRaghav Sundar, Izuma Nakayama, Sheraz R Markar, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 26, 2023
Artificial Intelligence in Clinical Oncology: From Data to Digital Pathology and TreatmentKirthika Senthil Kumar, Vanja Miskovic, Agata Blasiak, et al.
Annals of Surgical Oncology|December 23, 2022
Outcomes of a Phase II Study of Intraperitoneal Paclitaxel Plus Systemic Capecitabine and Oxaliplatin (XELOX) for Gastric Cancer with Peritoneal MetastasesDaryl K A Chia, Raghav Sundar, Guowei Kim, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|September 24, 2022
Reply to: Letter to editor on the article "Choice of PD-L1 immunohistochemistry assay influences clinical eligibility for gastric cancer immunotherapy"Joe Yeong, Chong Boon Teo, Ryan Yong Kiat Tay, et al.
Acta Oncologica (Stockholm, Sweden)|September 12, 2015
Hypothermia for preventing chemotherapy-induced neuropathy - a pilot study on safety and tolerability in healthy controlsAishwarya Bandla, Raghav Sundar, Lun-De Liao, et al.
Pageof 15

Showing results (41-50 of 149) with videos related to

Sort By:
Pageof 15
British Journal of Anaesthesia|February 20, 2024
FRailty in Australian patients admitted to Intensive care unit after eLective CANCER-related SURGery: a retrospective multicentre cohort study (FRAIL-CANCER-SURG study)Ryan R Ling, Ryo Ueno, Muhammad Alamgeer, et al.
Thoracic Cancer|March 8, 2018
Resisting resistance to cancer immunotherapyWalter Sze-Tung Lam, Louis Zizhao Wang, Raheleh Roudi, et al.
Journal of Cancer Research and Clinical Oncology|May 22, 2023
Effects of prior therapies on outcomes with trifluridine/tipiracil in patients with metastatic gastric/gastroesophageal junction cancer in a randomized phase III trial (TAGS)Kohei Shitara, Ben George, Julien Taieb, et al.
Annals of Surgical Oncology|May 30, 2025
A Feasibility Study of Mass-Based Response Drug Screening to Guide Personalized Hyperthermic Intraperitoneal Chemotherapy for Appendiceal and Colorectal Adenocarcinoma with Peritoneal MetastasisJustin M Bader, Ava Ospina, Sean Liu, et al.
Annals of Surgical Oncology|October 3, 2022
ASO Author Reflections: Combination Intra-Peritoneal and Systemic Chemotherapy for Gastric Cancer with Peritoneal MetastasesDaryl K A Chia, Jia Jun Ang, Raghav Sundar, et al.
Lancet (London, England)|May 4, 2025
Gastric cancerRaghav Sundar, Izuma Nakayama, Sheraz R Markar, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 26, 2023
Artificial Intelligence in Clinical Oncology: From Data to Digital Pathology and TreatmentKirthika Senthil Kumar, Vanja Miskovic, Agata Blasiak, et al.
Annals of Surgical Oncology|December 23, 2022
Outcomes of a Phase II Study of Intraperitoneal Paclitaxel Plus Systemic Capecitabine and Oxaliplatin (XELOX) for Gastric Cancer with Peritoneal MetastasesDaryl K A Chia, Raghav Sundar, Guowei Kim, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|September 24, 2022
Reply to: Letter to editor on the article "Choice of PD-L1 immunohistochemistry assay influences clinical eligibility for gastric cancer immunotherapy"Joe Yeong, Chong Boon Teo, Ryan Yong Kiat Tay, et al.
Acta Oncologica (Stockholm, Sweden)|September 12, 2015
Hypothermia for preventing chemotherapy-induced neuropathy - a pilot study on safety and tolerability in healthy controlsAishwarya Bandla, Raghav Sundar, Lun-De Liao, et al.
Pageof 15